{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T01:27:42Z","timestamp":1794014862873,"version":"4.8.0"},"reference-count":113,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:p>Diabetic kidney disease (DKD) is one of the leading causes of end-stage renal disease worldwide, and lipid metabolism disorder is a key factor in accelerating its progression. Among them, the impaired fatty acid oxidation (FAO) function of renal tissue constitutes one of the core pathological links of lipid metabolism disorders. In DKD, impaired FAO function can directly lead to lipid accumulation, mitochondrial stress, and trigger an inflammatory cascade, thereby promoting the occurrence and development of glomerulosclerosis and renal tubular injury. However, the efficacy of current DKD treatment strategies is still limited. Natural compounds (such as polyphenols, phenolic acids, alkaloids, glycosides, and carotenoids) have shown potential in renal protection due to their multi-target and multi-pathway characteristics. Studies have shown that regulating the FAO process in the context of lipid metabolism disorders is a crucial mechanism by which natural compounds can exert anti-DKD effects. It is worth noting that peroxisome proliferator-activated receptors (PPARs) are core transcription factors that regulate FAO. Specifically, these active ingredients can upregulate the expression of their downstream target genes by activating the PPAR signaling pathway (especially PPAR\u03b1), thereby improving FAO function, correcting abnormal lipid metabolism, and ultimately delaying the progression of renal pathological mechanisms such as inflammation and fibrosis. The above findings provide an essential scientific basis for the development of new, safe, and effective DKD therapeutic drugs.<\/jats:p>","DOI":"10.3389\/fnut.2025.1669557","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T04:24:07Z","timestamp":1760502247000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Natural compounds regulating fatty acid oxidation in the treatment of diabetic kidney disease"],"prefix":"10.3389","volume":"12","author":[{"given":"Jianing","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengqian","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songlin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12906-021-03477-x","article-title":"Astragalus mongholicus bunge and Panax notoginseng formula (a&P) improves renal mesangial cell damage in diabetic nephropathy by inhibiting the inflammatory response of infiltrated macrophages","volume":"22","author":"Lin","year":"2022","journal-title":"BMC Complement Med Ther"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"e23-00029","DOI":"10.1097\/imna-d-23-00029","article-title":"Update on the pathogenesis, diagnosis, and treatment of diabetic tubulopathy","volume":"11","author":"Liu","year":"2024","journal-title":"Integr Med Nephrol Androl"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2478\/jtim-2022-0049","article-title":"Irbesartan ameliorates diabetic kidney injury in db\/db mice by restoring circadian rhythm and cell cycle","volume":"12","author":"Zhao","year":"2024","journal-title":"J Transl Intern Med"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"395","DOI":"10.2478\/jtim-2023-0130","article-title":"Identification of functional heterogeneity of immune cells and tubular-immune cellular interplay action in diabetic kidney disease","volume":"12","author":"Bai","year":"2024","journal-title":"J Transl Intern Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"e00020","DOI":"10.1097\/imna-d-22-00020","article-title":"Efficacy of huangkui capsules in the treatment of diabetic kidney disease: a systematic review and using network pharmacology","volume":"10","author":"Geng","year":"2023","journal-title":"Integr Med Nephrol Androl"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"e00020","DOI":"10.1097\/IMNA-D-23-00020","article-title":"The potential of huangqi decoction for treating diabetic kidney disease","volume":"11","author":"Chen","year":"2024","journal-title":"Integr Med Nephrol Androl"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"112303","DOI":"10.1016\/j.intimp.2024.112303","article-title":"Hederagenin improves renal fibrosis in diabetic nephropathy by regulating Smad3\/NOX4\/SLC7A11 signaling-mediated tubular cell ferroptosis","volume":"135","author":"Jia","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"10882","DOI":"10.3390\/ijms231810882","article-title":"Recent advances in the emerging therapeutic strategies for diabetic kidney diseases","volume":"23","author":"Huang","year":"2022","journal-title":"Int J Mol Sci"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.2337\/dci22-0027","article-title":"Diabetes management in chronic kidney disease: a consensus report by the american diabetes association (ADA) and kidney disease: improving global outcomes (KDIGO)","volume":"45","author":"de Boer","year":"2022","journal-title":"Diabetes Care"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1320603","DOI":"10.3389\/fendo.2023.1320603","article-title":"Overview of the safety, efficiency, and potential mechanisms of finerenone for diabetic kidney diseases","volume":"14","author":"Chen","year":"2023","journal-title":"Front Endocrinol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13020-025-01150-w","article-title":"Traditional chinese medicine in diabetic kidney disease: multifaceted therapeutic mechanisms and research progress","volume":"20","author":"Cai","year":"2025","journal-title":"Chin Med"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"112560","DOI":"10.1016\/j.intimp.2024.112560","article-title":"Morroniside attenuates podocytes lipid deposition in diabetic nephropathy: a network pharmacology, molecular docking and experimental validation study","volume":"138","author":"Chen","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1549484","DOI":"10.3389\/fimmu.2025.1549484","article-title":"Targeting lipid metabolic reprogramming to alleviate diabetic kidney disease: molecular insights and therapeutic strategies","volume":"16","author":"Yu","year":"2025","journal-title":"Front Immunol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1336402","DOI":"10.3389\/fendo.2024.1336402","article-title":"Lipid metabolism disorder in diabetic kidney disease","volume":"15","author":"Han","year":"2024","journal-title":"Front Endocrinol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"2403652","DOI":"10.1080\/0886022X.2024.2403652","article-title":"Exploring the role and therapeutic potential of lipid metabolism in acute kidney injury","volume":"46","author":"Zhang","year":"2024","journal-title":"Ren Fail"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"2793823","DOI":"10.1155\/2021\/2793823","article-title":"Zishen qingre tongluo formula improves renal fatty acid oxidation and alleviated fibrosis via the regulation of the TGF-\u03b21\/Smad3 signaling pathway in hyperuricemic nephrology rats","volume":"2021","author":"Liu","year":"2021","journal-title":"Biomed Res Int"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"879","DOI":"10.2337\/db23-0811","article-title":"CPT1A protects podocytes from lipotoxicity and apoptosis in vitro and alleviates diabetic nephropathy in vivo","volume":"73","author":"Xie","year":"2024","journal-title":"Diabetes"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3389\/fmed.2020.00065","article-title":"Defective mitochondrial fatty acid oxidation and lipotoxicity in kidney diseases","volume":"7","author":"Jang","year":"2020","journal-title":"Front Med"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"3710","DOI":"10.7150\/ijbs.95216","article-title":"Lipid homeostasis in diabetic kidney disease","volume":"20","author":"Wang","year":"2024","journal-title":"Int J Biol Sci"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41419-022-04515-3","article-title":"STAT6 contributes to renal fibrosis by modulating PPAR\u03b1-mediated tubular fatty acid oxidation","volume":"13","author":"Li","year":"2022","journal-title":"Cell Death Dis"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"359","DOI":"10.2478\/jtim-2022-0053","article-title":"A comprehensive weighted gene co-expression network analysis uncovers potential targets in diabetic kidney disease","volume":"10","author":"Pan","year":"2023","journal-title":"J Transl Intern Med"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.3390\/pharmaceutics15051360","article-title":"Unraveling the crosstalk between lipids and NADPH oxidases in diabetic kidney disease","volume":"15","author":"Njeim","year":"2023","journal-title":"Pharmaceutics"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"F122","DOI":"10.1152\/ajprenal.00352.2017","article-title":"PPAR\u03b1 agonist fenofibrate enhances fatty acid \u03b2-oxidation and attenuates polycystic kidney and liver disease in mice","volume":"314","author":"Lakhia","year":"2018","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3390\/metabo11060372","article-title":"Pemafibrate protects against fatty acid-induced nephropathy by maintaining renal fatty acid metabolism","volume":"11","author":"Aomura","year":"2021","journal-title":"Meta"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3389\/fphar.2017.00545","article-title":"Pioglitazone improves mitochondrial function in the remnant kidney and protects against renal fibrosis in 5\/6 nephrectomized rats","volume":"8","author":"Sun","year":"2017","journal-title":"Front Pharmacol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.2337\/db06-1134","article-title":"Peroxisome proliferator activated receptor alpha\/gamma dual agonist tesaglitazar attenuates diabetic nephropathy in db\/db mice","volume":"56","author":"Cha","year":"2007","journal-title":"Diabetes"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"e0142303","DOI":"10.1371\/journal.pone.0142303","article-title":"Additive renoprotection by pioglitazone and fenofibrate against inflammatory, oxidative and apoptotic manifestations of cisplatin nephrotoxicity: modulation by PPARs","volume":"10","author":"Helmy","year":"2015","journal-title":"PLoS One"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1039\/d4np00009a","article-title":"Advances, opportunities, and challenges in methods for interrogating the structure activity relationships of natural products","volume":"41","author":"Ancajas","year":"2024","journal-title":"Nat Prod Rep"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1021\/acs.jnatprod.5b01055","article-title":"Natural products as sources of new drugs from 1981 to 2014","volume":"79","author":"Newman","year":"2016","journal-title":"J Nat Prod"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"e00026","DOI":"10.1097\/imna-d-22-00026","article-title":"New insights into traditional Chinese medicine in treatment of diabetic nephropathy","volume":"10","author":"Chung","year":"2023","journal-title":"Integr Med Nephrol Androl"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"800810","DOI":"10.3389\/fphar.2022.800810","article-title":"Natural products against renal fibrosis via modulation of SUMOylation","volume":"13","author":"Liu","year":"2022","journal-title":"Front Pharmacol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"115088","DOI":"10.1016\/j.biopha.2023.115088","article-title":"Advances in the pharmacological study of Chinese herbal medicine to alleviate diabetic nephropathy by improving mitochondrial oxidative stress","volume":"165","author":"Chen","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"ref34","first-page":"110711","article-title":"Regulation of renal lipid deposition in diabetic nephropathy on morroniside via inhibition of NF-KB\/TNF-a\/SREBP1c signaling pathway","volume-title":"Chem Biol Interact","author":"Zhu","year":"2023"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"e00033","DOI":"10.1097\/imna-d-22-00033","article-title":"Insights into the functional mechanism of diabetic kidney disease treatment with sinensetin based on network pharmacology and molecular docking","volume":"10","author":"Zhou","year":"2023","journal-title":"Integr Med Nephrol Androl"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1624077","DOI":"10.3389\/fphys.2025.1624077","article-title":"The role of natural products in improving lipid metabolism disorder-induced mitochondrial dysfunction of diabetic kidney disease","volume":"16","author":"Deng","year":"2025","journal-title":"Front Physiol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"642581","DOI":"10.3389\/fpls.2021.642581","article-title":"Diversity of chemical structures and biosynthesis of polyphenols in nut-bearing species","volume":"12","author":"Aneklaphakij","year":"2021","journal-title":"Front Plant Sci"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"6110","DOI":"10.3390\/ijms22116110","article-title":"Natural polyphenols in metabolic syndrome: protective mechanisms and clinical applications","volume":"22","author":"Zhang","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"105225","DOI":"10.1016\/j.neubiorev.2023.105225","article-title":"Polyphenols as novel interventions for depression: exploring the efficacy, mechanisms of action, and implications for future research","volume":"151","author":"Gamage","year":"2023","journal-title":"Neurosci Biobehav Rev"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"4714914","DOI":"10.1155\/2022\/4714914","article-title":"Impact of phytochemicals on PPAR receptors: implications for disease treatments","volume":"2022","author":"Enayati","year":"2022","journal-title":"PPAR Res"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"115588","DOI":"10.1016\/j.fct.2025.115588","article-title":"Resveratrol ameliorates streptozotocin induced renal inflammation and promotes autophagy by mediating the SphK1 pathway via Sirt1 in wistar rats","volume":"203","author":"Feng","year":"2025","journal-title":"Food Chem Toxicol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"112164","DOI":"10.1016\/j.biopha.2021.112164","article-title":"Resveratrol (RV): a pharmacological review and call for further research","volume":"143","author":"Zhang","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00280-010-1525-4","article-title":"Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats","volume":"68","author":"Kapetanovic","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"6042","DOI":"10.1039\/c9fo01075k","article-title":"The effects of resveratrol on metabolic status in patients with type 2 diabetes mellitus and coronary heart disease","volume":"10","author":"A","year":"2019","journal-title":"Food Funct"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s00125-012-2747-2","article-title":"Resveratrol prevents renal lipotoxicity and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK-SIRT1-PGC1\u03b1 axis in db\/db mice","volume":"56","author":"Kim","year":"2013","journal-title":"Diabetologia"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12967-016-0922-9","article-title":"Resveratrol increases AdipoR1 and AdipoR2 expression in type 2 diabetic nephropathy","volume":"14","author":"Park","year":"2016","journal-title":"J Transl Med"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"e13608","DOI":"10.1111\/1753-0407.13608","article-title":"Resveratrol delays the progression of diabetic nephropathy through multiple pathways: A dose-response meta-analysis based on animal models","volume":"16","author":"Liu","year":"2024","journal-title":"J Diabetes"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"10767","DOI":"10.1155\/2007\/10767","article-title":"Curcumin (1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) blocks the chemotaxis of neutrophils by inhibiting signal transduction through IL-8 receptors","volume":"2007","author":"Takahashi","year":"2007","journal-title":"Mediat Inflamm"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.phymed.2018.09.210","article-title":"Curcumin relieved cisplatin-induced kidney inflammation through inhibiting mincle-maintained M1 macrophage phenotype","volume":"52","author":"Tan","year":"2019","journal-title":"Phytomedicine"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3390\/nu14010231","article-title":"Curcumin supplementation (meriva\u00ae) modulates inflammation, lipid peroxidation and gut microbiota composition in chronic kidney disease","volume":"14","author":"Pivari","year":"2022","journal-title":"Nutrients"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s10928-020-09675-3","article-title":"Pharmacokinetics and pharmacodynamics of three oral formulations of curcumin in rats","volume":"47","author":"Wang","year":"2020","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"6109406","DOI":"10.1155\/2021\/6109406","article-title":"Effect of curcumin on diabetic kidney disease: a systematic review and meta-analysis of randomized, double-blind, placebo-controlled clinical trials","volume":"2021","author":"Jie","year":"2021","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1007\/s12272-024-01521-1","article-title":"Curcumin targets CXCL16-mediated podocyte injury and lipid accumulation in diabetic kidney disease treatment","volume":"47","author":"Chen","year":"2024","journal-title":"Arch Pharm Res"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.3390\/molecules27082498","article-title":"Health benefits of quercetin in age-related diseases","volume":"27","author":"Deepika","year":"2022","journal-title":"Molecules"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/ptr.6507","article-title":"Quercetin protects against cisplatin-induced acute kidney injury by inhibiting mincle\/syk\/NF-\u03baB signaling maintained macrophage inflammation","volume":"34","author":"Tan","year":"2020","journal-title":"Phytother Res"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"616219","DOI":"10.3389\/fcell.2021.616219","article-title":"Effect of quercetin on lipids metabolism through modulating the gut microbial and AMPK\/PPAR signaling pathway in broilers","volume":"9","author":"Wang","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1016\/j.jnutbio.2015.06.005","article-title":"The inhibitory effects of quercetin on obesity and obesity-induced inflammation by regulation of MAPK signaling","volume":"26","author":"Seo","year":"2015","journal-title":"J Nutr Biochem"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"35460","DOI":"10.1038\/srep35460","article-title":"Pharmacokinetic comparison between quercetin and quercetin 3-O-\u03b2-glucuronide in rats by UHPLC-MS\/MS","volume":"6","author":"Yang","year":"2016","journal-title":"Sci Rep"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3945\/an.111.001271","article-title":"Therapeutic potential of quercetin to decrease blood pressure: review of efficacy and mechanisms","volume":"3","author":"Larson","year":"2012","journal-title":"Adv Nutr"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1042\/BJ20020377","article-title":"Inhibition of peroxisome proliferator-activated receptor (PPAR)-mediated keratinocyte differentiation by lipoxygenase inhibitors","volume":"366","author":"Thuillier","year":"2002","journal-title":"Biochem J"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1194\/jlr.M038786","article-title":"Quercetin reduces obesity-associated ATM infiltration and inflammation in mice: a mechanism including AMPK\u03b11\/SIRT1","volume":"55","author":"Dong","year":"2014","journal-title":"J Lipid Res"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.3390\/ijms23031044","article-title":"Quercetin reduces lipid accumulation in a cell model of NAFLD by inhibiting de novo fatty acid synthesis through the acetyl-CoA carboxylase 1\/AMPK\/PP2A axis","volume":"23","author":"Gnoni","year":"2022","journal-title":"Int J Mol Sci"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"155705","DOI":"10.1016\/j.phymed.2024.155705","article-title":"Senolytic combination of dasatinib and quercetin attenuates renal damage in diabetic kidney disease","volume":"130","author":"Guo","year":"2024","journal-title":"Phytomedicine"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"1406619","DOI":"10.3389\/fphar.2024.1406619","article-title":"Naringenin as potent anticancer phytocompound in breast carcinoma: from mechanistic approach to nanoformulations based therapeutics","volume":"15","author":"Elsori","year":"2024","journal-title":"Front Pharmacol"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"114343","DOI":"10.1016\/j.colsurfb.2024.114343","article-title":"Naringenin loaded fucoidan\/polyvinylpyrrolidone nanoparticles protect against folic acid induced acute kidney injury in vitro and in vivo","volume":"245","author":"Jiang","year":"2025","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1021\/acs.jafc.2c01513","article-title":"Naringenin ameliorates hyperuricemia by regulating renal uric acid excretion via the PI3K\/AKT signaling pathway and renal inflammation through the NF-\u03baB signaling pathway","volume":"71","author":"Yang","year":"2023","journal-title":"J Agric Food Chem"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"110","DOI":"10.7150\/ijms.102088","article-title":"Naringenin mitigates dasatinib-induced kidney damage by modulating antioxidant defense, inflammation, and apoptosis pathways","volume":"22","author":"Alhazzani","year":"2025","journal-title":"Int J Med Sci"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.fshw.2022.10.043","article-title":"Naringenin inhibits lipid accumulation by activating the AMPK pathway in vivo and vitro","volume":"12","author":"Cai","year":"2023","journal-title":"Food Sci Human Wellness"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"9033","DOI":"10.3390\/molecules27249033","article-title":"Extraction of naringin from pomelo and its therapeutic potentials against hyperlipidemia","volume":"27","author":"Yu","year":"2022","journal-title":"Molecules"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.apsb.2017.05.005","article-title":"The potential of natural products for targeting PPAR\u03b1","volume":"7","author":"Rigano","year":"2017","journal-title":"Acta Pharm Sin B"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"364","DOI":"10.3389\/fphar.2020.00364","article-title":"Pharmacokinetics and metabolism of naringin and active metabolite naringenin in rats, dogs, humans, and the differences between species","volume":"11","author":"Bai","year":"2020","journal-title":"Front Pharmacol"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"e70626","DOI":"10.1002\/fsn3.70626","article-title":"An updated review of the anticancer mechanisms and therapeutic potential of naringenin","volume":"13","author":"Noman","year":"2025","journal-title":"Food Sci Nutr"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1002\/jat.1343","article-title":"Combined treatment with naringin and vitamin C ameliorates streptozotocin-induced diabetes in male wistar rats","volume":"28","author":"Punithavathi","year":"2008","journal-title":"J Appl Toxicol"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/FJC.0b013e31823827a4","article-title":"Naringin ameliorates atherogenic dyslipidemia but not hyperglycemia in rats with type 1 diabetes","volume":"59","author":"Xulu","year":"2012","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.cbi.2019.05.004","article-title":"Activation of 20-HETE\/PPARs involved in Reno-therapeutic effect of naringenin on diabetic nephropathy","volume":"307","author":"Ding","year":"2019","journal-title":"Chem Biol Interact"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.3390\/antiox11122307","article-title":"Oxybaphus himalaicus mitigates lipopolysaccharide-induced acute kidney injury by inhibiting TLR4\/MD2 complex formation","volume":"11","author":"Zhan","year":"2022","journal-title":"Antioxidants"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"106474","DOI":"10.1016\/j.fitote.2025.106474","article-title":"Oxybaphus himalaicus alleviates diabetic kidney disease by suppressing the lipid metabolism and inflammation via PPAR\u03b1 signaling","volume":"182","author":"Qu","year":"2025","journal-title":"Fitoterapia"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"119398","DOI":"10.1016\/j.jep.2025.119398","article-title":"Boeravinone C ameliorates lipid accumulation and inflammation in diabetic kidney disease by activating PPAR\u03b1 signaling","volume":"342","author":"Cheng","year":"2025","journal-title":"J Ethnopharmacol"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"4790","DOI":"10.3390\/molecules29204790","article-title":"Research progress on the mechanism for improving glucose and lipid metabolism disorders using phenolic acid components from medicinal and edible homologous plants","volume":"29","author":"Sun","year":"2024","journal-title":"Molecules"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"7286","DOI":"10.3390\/molecules27217286","article-title":"Anticancer, cardio-protective and anti-inflammatory potential of natural-sources-derived phenolic acids","volume":"27","author":"Afnan","year":"2022","journal-title":"Mol (Basel Switz)"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"105109","DOI":"10.1016\/j.phrs.2020.105109","article-title":"New progress in the pharmacology of protocatechuic acid: a compound ingested in daily foods and herbs frequently and heavily","volume":"161","author":"Song","year":"2020","journal-title":"Pharmacol Res"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"7060","DOI":"10.1021\/acs.jafc.9b02647","article-title":"Protocatechuic acid-ameliorated endothelial oxidative stress through regulating acetylation level via CD36\/AMPK pathway","volume":"67","author":"Han","year":"2019","journal-title":"J Agric Food Chem"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.fct.2013.01.005","article-title":"Antibacterial activity of veronica montana L. extract and of protocatechuic acid incorporated in a food system","volume":"55","author":"Stojkovi\u0107","year":"2013","journal-title":"Food Chem Toxicol"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"3873","DOI":"10.3390\/molecules24213873","article-title":"Comparative pharmacokinetics of gallic acid, protocatechuic acid, and quercitrin in normal and pyelonephritis rats after oral administration of a polygonum capitatum extract","volume":"24","author":"Huang","year":"2019","journal-title":"Molecules"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"5117","DOI":"10.1021\/jf200103f","article-title":"Antiglycative effects of protocatechuic acid in the kidneys of diabetic mice","volume":"59","author":"Lin","year":"2011","journal-title":"J Agric Food Chem"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"e2300451","DOI":"10.1002\/mnfr.202300451","article-title":"Dietary achievable dose of protocatechuic acid, a metabolite of flavonoids, inhibits high-fat diet-induced obesity in mice","volume":"68","author":"Xiang","year":"2024","journal-title":"Mol Nutr Food Res"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"4166","DOI":"10.1111\/bph.15159","article-title":"Sirtuin 3-mediated deacetylation of acyl-CoA synthetase family member 3 by protocatechuic acid attenuates non-alcoholic fatty liver disease","volume":"177","author":"Sun","year":"2020","journal-title":"Br J Pharmacol"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.3390\/molecules26071836","article-title":"Alkaloids used as medicines: structural phytochemistry meets biodiversity-an update and forward look","volume":"26","author":"Heinrich","year":"2021","journal-title":"Molecules"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"116406","DOI":"10.1016\/j.biopha.2024.116406","article-title":"Bioactivity and mechanism of action of sanguinarine and its derivatives in the past 10 years","volume":"173","author":"Huang","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.3390\/molecules28073149","article-title":"Papaverine: a miraculous alkaloid from opium and its multimedicinal application","volume":"28","author":"Ashrafi","year":"2023","journal-title":"Molecules"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"11109","DOI":"10.3390\/ijms222011109","article-title":"Rutaecarpine, an alkaloid from evodia rutaecarpa, can prevent platelet activation in humans and reduce microvascular thrombosis in mice: crucial role of the PI3K\/akt\/GSK3\u03b2 signal axis through a cyclic nucleotides\/VASP-independent mechanism","volume":"22","author":"Huang","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"2290930","DOI":"10.1080\/0886022X.2023.2290930","article-title":"Research progress of natural active compounds on improving podocyte function to reduce proteinuria in diabetic kidney disease","volume":"45","author":"Gong","year":"2023","journal-title":"Ren Fail"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1080\/0886022X.2022.2079525","article-title":"Berberine protects diabetic nephropathy by suppressing epithelial-to-mesenchymal transition involving the inactivation of the NLRP3 inflammasome","volume":"44","author":"Ma","year":"2022","journal-title":"Ren Fail"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"1112088","DOI":"10.3389\/fphar.2023.1112088","article-title":"Advances of berberine against metabolic syndrome-associated kidney disease: regarding effect and mechanism","volume":"14","author":"Liu","year":"2023","journal-title":"Front Pharmacol"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"973","DOI":"10.3390\/biology12070973","article-title":"Berberine and its study as an antidiabetic compound","volume":"12","author":"Utami","year":"2023","journal-title":"Biology"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.metabol.2008.01.013","article-title":"Efficacy of berberine in patients with type 2 diabetes","volume":"57","author":"Yin","year":"2008","journal-title":"Metab Clin Exp"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"1015045","DOI":"10.3389\/fphar.2022.1015045","article-title":"Glucose-lowering effect of berberine on type 2 diabetes: a systematic review and meta-analysis","volume":"13","author":"Xie","year":"2022","journal-title":"Front Pharmacol"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"729384","DOI":"10.3389\/fphar.2021.729384","article-title":"Berberine reduces lipid accumulation by promoting fatty acid oxidation in renal tubular epithelial cells of the diabetic kidney","volume":"12","author":"Rong","year":"2022","journal-title":"Front Pharmacol"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1142\/S0192415X2350091X","article-title":"Coptisine, the characteristic constituent from coptis chinensis, exhibits significant therapeutic potential in treating cancers, metabolic and inflammatory diseases","volume":"51","author":"Lu","year":"2023","journal-title":"Am J Chin Med"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"e3918","DOI":"10.1002\/bmc.3918","article-title":"Pharmacokinetics and tissue distribution of coptisine in rats after oral administration by liquid chromatography-mass spectrometry","volume":"31","author":"Yan","year":"2017","journal-title":"Biomed Chromatogr"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00210-019-01710-6","article-title":"Coptisine ameliorates renal injury in diabetic rats through the activation of Nrf2 signaling pathway","volume":"393","author":"Zhai","year":"2020","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"20220568","DOI":"10.1515\/biol-2022-0568","article-title":"Coptisine mitigates diabetic nephropathy via repressing the NRLP3 inflammasome","volume":"18","author":"Zhai","year":"2023","journal-title":"Open Life Sci"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"5465","DOI":"10.1007\/s00210-024-03617-3","article-title":"Coptisine inhibits lipid accumulation in high glucose- and palmitic acid-induced HK-2 cells by regulating the AMPK\/ACC\/CPT-1 signaling pathway","volume":"398","author":"Tao","year":"2025","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"4423","DOI":"10.1021\/acs.jafc.1c00130","article-title":"1H NMR metabolomics and full-length RNA-seq reveal effects of acylated and nonacylated anthocyanins on hepatic metabolites and gene expression in zucker diabetic fatty rats","volume":"69","author":"Chen","year":"2021","journal-title":"J Agric Food Chem"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"885","DOI":"10.3390\/biom15060885","article-title":"Cardiac glycosides: from natural defense molecules to emerging therapeutic agents","volume":"15","author":"Ponce","year":"2025","journal-title":"Biomolecules"},{"key":"ref106","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1002\/ptr.5487","article-title":"Pharmacological effects of glycyrrhiza spp. and its bioactive constituents: update and review","volume":"29","author":"Hosseinzadeh","year":"2015","journal-title":"Phytother res: PTR"},{"key":"ref107","doi-asserted-by":"publisher","first-page":"108314","DOI":"10.1016\/j.pharmthera.2022.108314","article-title":"A natural products solution to diabetic nephropathy therapy","volume":"241","author":"Hu","year":"2023","journal-title":"Pharmacol Ther"},{"key":"ref108","doi-asserted-by":"publisher","first-page":"2865912","DOI":"10.1155\/2017\/2865912","article-title":"Glycyrrhizic acid prevents diabetic nephropathy by activating AMPK\/SIRT1\/PGC-1\u03b1 signaling in db\/db mice","volume":"2017","author":"Hou","year":"2017","journal-title":"J Diabetes Res"},{"key":"ref109","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.kint.2020.09.037","article-title":"Targeting energy pathways in kidney disease: the roles of sirtuins, AMPK, and PGC1\u03b1","volume":"99","author":"Clark","year":"2021","journal-title":"Kidney Int"},{"key":"ref110","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ejphar.2017.04.021","article-title":"Protective effects of glycyrrhizic acid against non-alcoholic fatty liver disease in mice","volume":"806","author":"Sun","year":"2017","journal-title":"Eur J Pharmacol"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"e140695","DOI":"10.1172\/JCI140695","article-title":"Renal tubule Cpt1a overexpression protects from kidney fibrosis by restoring mitochondrial homeostasis","volume":"131","author":"Miguel","year":"2021","journal-title":"J Clin Invest"},{"key":"ref112","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1210\/er.2018-00064","article-title":"Molecular actions of PPAR\u03b1 in lipid metabolism and inflammation","volume":"39","author":"Bougarne","year":"2018","journal-title":"Endocr Rev"},{"key":"ref113","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1056\/NEJMoa2210645","article-title":"Triglyceride lowering with pemafibrate to reduce cardiovascular risk","volume":"387","author":"Das Pradhan","year":"2022","journal-title":"N Engl J Med"}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2025.1669557\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T04:24:08Z","timestamp":1760502248000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2025.1669557\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":113,"alternative-id":["10.3389\/fnut.2025.1669557"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2025.1669557","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"article-number":"1669557"}}